Cloud DX Inc. (CDXFF)
For informational purposes only. Not financial advice. Analysis by Sedat ANAK, Founder & Editor-in-Chief | AI-powered analysis. Data sourced from SEC filings and institutional-grade financial providers. Editorially reviewed. Not financial advice.
Cloud DX Inc. (CDXFF) trades at $0.09 with AI Score 54/100 (Grade B). Cloud DX Inc. operates a remote patient monitoring platform, offering end-to-end virtual healthcare solutions. Market cap: $9.75M, Sector: Healthcare.
Price live · AI analysis from Mar 18, 2026Analyst Coverage for CDXFF: CDXFF does not currently have published analyst price targets in our coverage universe. This is common for smaller-cap names with limited Wall Street coverage. In the absence of analyst consensus, our AI model evaluates CDXFF against Healthcare peers across nine fundamental dimensions and assigns a mixed fundamental profile based on the underlying data.
CDXFF: 2/6 perspectives are bullish. Dominant signal: Ray Dalio bullish.
How is this calculated? →Cloud DX Inc. (CDXFF) Healthcare & Pipeline Overview
Cloud DX Inc. provides a remote patient monitoring platform, enabling virtual healthcare for chronic illnesses and post-operative recovery. Their connected health kits and VITALITI monitor offer comprehensive data collection, serving hospitals, academic institutions, and health authorities in both Canada and the United States.
What Is the Investment Thesis for CDXFF?
Cloud DX Inc. presents a notable research candidate within the expanding telehealth market. The company's comprehensive remote patient monitoring platform addresses the growing need for virtual healthcare solutions, particularly for chronic disease management and post-operative care. Key value drivers include increasing adoption of telehealth services, strategic partnerships with healthcare providers, and expansion into new geographic markets. The company's negative profit margin of -571.0% and negative gross margin of -247.9% indicate significant challenges in achieving profitability. Upcoming catalysts include potential contract wins with large hospital networks and expansion of the VITALITI product line. Investors should monitor the company's ability to improve its financial performance and secure sustainable revenue streams.
Based on FMP financials and quantitative analysis
CDXFF Key Highlights
- Market Cap of $9.75M reflects its small size and growth potential within the telehealth market.
- P/E ratio of -1.13 indicates the company is currently not profitable.
- Profit Margin of -571.0% highlights significant challenges in achieving profitability.
- Gross Margin of -247.9% suggests high costs associated with its services.
- Beta of 0.44 indicates lower volatility compared to the overall market.
Who Are CDXFF's Competitors?
CDXFF is benchmarked below against 8 industry peers on price, market cap, and our AI MoonshotScore.
| Company | Price | Change | Market Cap | AI Score |
|---|---|---|---|---|
| ATBPF Antibe Therapeutics Inc. | $0.22 | -0.19% | $11.43M | 44 |
| CNPOF RIV Capital Inc. | $0.08 | +0.00% | $10.96M | 36 |
| CRBKF Carebook Technologies Inc. | $0.03 | +0.00% | $6.84M | 64 |
| DOCRF CloudMD Software & Services Inc. | $0.02 | -19.29% | $6.25M | 38 |
| CARL CARLSMED, INC. | $11.90 | +4.94% | $323.50M | 70 |
| HNGE Hinge Health, Inc. | $89.42 | +6.39% | $6.92B | 68 |
| VRHI Veri Medtech Holdings Inc. | $1.95 | +0.00% | $39.09M | 67 |
| AKLI Akili, Inc. | $0.43 | +0.25% | $34.10M | 67 |
AI Score by Stock Expert AI · Price data: FMP / Yahoo Finance
What Are CDXFF's Key Strengths?
- Comprehensive remote patient monitoring platform.
- Connected Health Kits with various monitoring devices.
- VITALITI vital sign monitor with advanced capabilities.
- Established relationships with healthcare providers.
What Are CDXFF's Weaknesses?
- Negative profit margin and gross margin.
- Limited market share compared to larger competitors.
- Reliance on third-party suppliers for some medical devices.
- OTC market listing may limit investor access.
What Could Drive CDXFF Stock Higher?
- Potential contract wins with large hospital networks in the US.
- Expansion of the VITALITI product line with new features and capabilities.
- Increasing adoption of telehealth and remote patient monitoring services.
- Strategic partnerships with healthcare providers to expand market reach.
What Are the Key Risks for CDXFF?
- Weak fundamentals — a Piotroski F-Score of 3/9 flags soft profitability, leverage or efficiency.
- Intense competition in the telehealth market.
- Changes in government regulations and reimbursement policies.
- Negative profit margin and gross margin.
- Limited market share compared to larger competitors.
- Reliance on third-party suppliers for some medical devices.
What Are the Growth Opportunities for CDXFF?
- Expansion into the US Market: Cloud DX has the opportunity to further penetrate the US market, leveraging the increasing adoption of telehealth solutions and the growing demand for remote patient monitoring services. The US telehealth market is projected to reach $55.5 billion by 2026, providing a significant growth runway for Cloud DX. Success in this market hinges on securing partnerships with US-based healthcare providers and demonstrating the value of its platform in improving patient outcomes and reducing healthcare costs.
- Strategic Partnerships with Healthcare Providers: Forming strategic partnerships with hospitals, clinics, and other healthcare providers can significantly expand Cloud DX's reach and market penetration. These partnerships can provide access to a larger patient base and facilitate the integration of Cloud DX's platform into existing healthcare workflows. The company can leverage these partnerships to drive adoption of its connected health kits and VITALITI monitor, generating recurring revenue streams and establishing a strong foothold in the telehealth market.
- Development of New Product Features and Services: Investing in the development of new product features and services can enhance the value proposition of Cloud DX's platform and attract new customers. This includes incorporating advanced analytics capabilities, integrating with other healthcare IT systems, and expanding the range of supported medical devices. By continuously innovating and adapting to the evolving needs of the market, Cloud DX can maintain a competitive edge and drive long-term growth.
- Focus on Chronic Disease Management: Cloud DX can capitalize on the growing prevalence of chronic diseases by focusing its efforts on developing specialized solutions for managing conditions such as diabetes, heart disease, and respiratory illnesses. The chronic disease management market is estimated to reach $20 billion by 2028, presenting a significant opportunity for Cloud DX to establish itself as a leader in this space. This involves tailoring its platform to meet the specific needs of patients with chronic conditions and demonstrating the effectiveness of its solutions in improving patient outcomes and reducing healthcare costs.
- Leveraging Government Incentives and Reimbursement Policies: Cloud DX can benefit from government incentives and reimbursement policies that support the adoption of telehealth and remote patient monitoring services. Many countries are implementing policies to encourage the use of telehealth, including providing reimbursement for remote patient monitoring services. By staying informed about these policies and actively engaging with government agencies, Cloud DX can position itself to take advantage of these opportunities and drive adoption of its platform.
What Opportunities Does CDXFF Have?
- Expansion into the US market.
- Strategic partnerships with healthcare providers.
- Development of new product features and services.
- Focus on chronic disease management.
What Threats Does CDXFF Face?
- Intense competition in the telehealth market.
- Changes in government regulations and reimbursement policies.
- Technological advancements by competitors.
- Economic downturn affecting healthcare spending.
What Are CDXFF's Competitive Advantages?
- Proprietary Cloud DX Connected Health platform provides a comprehensive remote patient monitoring solution.
- Established relationships with academic institutions, hospitals, and health authorities.
- VITALITI vital sign monitor offers a unique and advanced monitoring capability.
- Focus on chronic disease management provides a specialized market niche.
What Does CDXFF Do?
Cloud DX Inc. is a remote patient monitoring company that provides an end-to-end virtual healthcare platform. Founded with the vision of transforming healthcare delivery through technology, the company focuses on enabling remote monitoring of patients with chronic illnesses such as chronic obstructive pulmonary disease (COPD) and congestive heart failure. Their platform also supports patients recovering from surgery and those managing COVID-19 outside of traditional hospital settings. Cloud DX's core offering is the Cloud DX Connected Health platform, which includes connected health kits featuring devices like Bluetooth pulse oximeters and wireless weight scales. These kits can be expanded with optional third-party devices such as Bluetooth blood pressure monitors, digital thermometers, and glucose meters. The company also offers VITALITI, a vital sign monitor capable of measuring electrocardiograph (ECG), heart rate, oxygen saturation, respiration rate, core body temperature, blood pressure, movement, steps, and posture. Cloud DX serves a diverse range of clients, including academic institutions, large hospitals, and provincial health authorities in Canada, as well as physician practices and hospitals in the United States. The company's solutions aim to improve patient outcomes, reduce hospital readmissions, and enhance the efficiency of healthcare delivery. Headquartered in Kitchener, Canada, Cloud DX is committed to expanding its reach and impact in the rapidly evolving telehealth market.
What Products and Services Does CDXFF Offer?
- Offers Cloud DX Connected Health, an end-to-end virtual healthcare platform.
- Monitors patients with chronic illnesses like COPD and congestive heart failure remotely.
- Supports patients recovering from surgery and COVID-19 patients outside hospitals.
- Provides Cloud DX Connected Health Kits with Bluetooth pulse oximeters and wireless weight scales.
- Offers VITALITI, a vital sign monitor for measuring ECG, heart rate, and other vital signs.
- Serves academic institutions, hospitals, and health authorities in Canada and the US.
How Does CDXFF Make Money?
- Sells Cloud DX Connected Health Kits to healthcare providers and patients.
- Generates revenue through subscription fees for access to the Cloud DX Connected Health platform.
- Offers VITALITI vital sign monitors for continuous patient monitoring.
- Partners with third-party suppliers for additional medical devices.
What Industry Does CDXFF Operate In?
Cloud DX Inc. operates within the rapidly growing telehealth and remote patient monitoring market. The industry is driven by factors such as an aging population, increasing prevalence of chronic diseases, and advancements in technology. The competitive landscape includes companies like ATBPF (Air T, Inc.), BNOEF (BioNxt Solutions Inc.), CNPOF (Care Net Population Health Management Inc.), CRBKF (Carebook Technologies Inc.), and DOCRF (CloudMD Software & Services Inc.), each offering various telehealth solutions. Cloud DX differentiates itself through its comprehensive platform and focus on chronic disease management.
Who Are CDXFF's Key Customers?
- Academic institutions in Canada and the United States.
- Large hospitals and healthcare systems.
- Provincial health authorities in Canada.
- Physician practices in the United States.
How Cloud DX Inc. Is Valued
Cloud DX Inc. carries a market capitalization of $9.75M, placing it in the micro-cap category. Relative to its peer group, CDXFF's quantitative score of 54/100 is roughly in line with the peer average of 50/100.
Company Profile
Cloud DX Inc. operates in the Medical - Healthcare Information Services industry within the Healthcare sector. It is headquartered in Kitchener, US. The company is led by CEO Robert Manson Kaul. CDXFF has traded publicly since 2021.
ROE 70%Key Financial Metrics
Return on equity for Cloud DX Inc. stands at 70.2%, a gauge of how efficiently it converts shareholder capital into profit. Its free cash flow yield is -52.2%, a gauge of the cash the business throws off relative to its market value. A current ratio of 0.06 means current liabilities exceed short-term assets, a liquidity point worth watching. Its earnings yield is -88.9%, the inverse of the P/E and a quick read on earnings relative to price.
F-Score 3/9Financial Health
Cloud DX Inc.'s Piotroski F-Score is 3/9, a 9-point checklist of profitability, leverage and efficiency — flagging fundamental weakness worth scrutiny.
CDXFF Financials
Fundamental Snapshot
Based on FMP financials and quantitative analysis
Bull Case vs Bear Case
Bull Case
- Comprehensive remote patient monitoring platform.
- Connected Health Kits with various monitoring devices.
- VITALITI vital sign monitor with advanced capabilities.
- Established relationships with healthcare providers.
Bear Case
- Negative profit margin and gross margin.
- Limited market share compared to larger competitors.
- Reliance on third-party suppliers for some medical devices.
- OTC market listing may limit investor access.
AI-generated arguments based on insider flow, news sentiment and technicals — not financial advice · July 2026
CDXFF Latest News
No recent news available for CDXFF.
CDXFF Analyst Consensus
Consensus Rating
Aggregated Buy/Hold/Sell recommendations from Benzinga, Yahoo Finance, and Finnhub for CDXFF.
Price Targets
Wall Street price target analysis for CDXFF.
CDXFF MoonshotScore
What does this score mean?
The MoonshotScore rates CDXFF's growth potential on a scale of 0-100 across multiple factors including innovation, market disruption, financial health, and momentum.
Leadership: Robert Manson Kaul
CEO
Robert Manson Kaul serves as the CEO of Cloud DX Inc. His background includes extensive experience in the healthcare technology sector, with a focus on developing and commercializing innovative solutions. Prior to joining Cloud DX, he held leadership positions at various healthcare companies, where he was responsible for driving growth and expanding market reach. He has a strong track record of building successful teams and executing strategic initiatives.
Track Record: Under Robert Manson Kaul's leadership, Cloud DX Inc. has focused on expanding its remote patient monitoring platform and securing partnerships with healthcare providers. Key achievements include the development and launch of the VITALITI vital sign monitor and the expansion of the company's presence in the US market. He has also overseen the implementation of strategic initiatives aimed at improving patient outcomes and reducing healthcare costs.
CDXFF OTC Market Information
The OTC Other tier represents the lowest tier of the OTC market, indicating that Cloud DX Inc. may not meet the minimum financial or reporting requirements for higher tiers like OTCQX or OTCQB. Companies in this tier may have limited financial disclosures and may not be subject to the same regulatory oversight as companies listed on major exchanges like the NYSE or NASDAQ. Investing in companies on the OTC Other tier carries higher risks due to the potential for limited information and liquidity.
- OTC Tier: OTC Other
- Disclosure Status: Unknown
- Limited financial disclosure and regulatory oversight.
- Higher price volatility due to lower trading volume.
- Potential for fraud or manipulation.
- Difficulty in obtaining accurate and timely information.
- Limited liquidity and wider bid-ask spreads.
- Verify the company's registration and legal standing.
- Review available financial statements and disclosures.
- Assess the company's business model and competitive landscape.
- Evaluate the management team and their track record.
- Understand the risks associated with investing in OTC stocks.
- Consult with a financial advisor before investing.
- Check for any regulatory actions or investigations.
- Established relationships with academic institutions and hospitals.
- Proprietary Cloud DX Connected Health platform and VITALITI monitor.
- Focus on chronic disease management.
- Presence in both Canadian and US markets.
What Investors Ask About Cloud DX Inc. (CDXFF) — Healthcare
What does Cloud DX Inc. do?
Cloud DX Inc. operates as a remote patient monitoring company, offering the Cloud DX Connected Health platform, an end-to-end virtual healthcare solution. The company provides connected health kits and the VITALITI vital sign monitor to enable remote monitoring of patients with chronic illnesses, those recovering from surgery, and COVID-19 patients outside hospitals. Cloud DX serves academic institutions, hospitals, and health authorities in Canada and the United States, facilitating improved patient outcomes and efficient healthcare delivery through technology.
What do analysts say about CDXFF stock?
As of March 18, 2026, there is no readily available analyst consensus on CDXFF stock due to its OTC listing and limited coverage. Key valuation metrics indicate that the company is currently unprofitable, with a negative P/E ratio and negative profit and gross margins. Growth considerations include the company's potential to expand its market share in the telehealth industry and secure strategic partnerships. Investors should conduct their own due diligence and consider the risks associated with investing in OTC stocks.
What are the main risks for CDXFF?
The main risks for Cloud DX Inc. include intense competition in the telehealth market, potential changes in government regulations and reimbursement policies, and the company's current lack of profitability. Additionally, the company faces risks associated with its reliance on third-party suppliers for some medical devices and its limited market share compared to larger competitors. Investing in CDXFF also carries risks specific to OTC stocks, such as limited financial disclosure and regulatory oversight, higher price volatility, and liquidity constraints.
What are the key factors to evaluate for CDXFF?
Cloud DX Inc. (CDXFF) holds an AI score of 54/100 (moderate). Not financial advice.
How frequently does CDXFF data refresh on this page?
CDXFF prices update in real time during U.S. market hours. Fundamentals refresh after quarterly filings; analyst ratings and AI insights update daily; news is aggregated continuously.
What has driven CDXFF's recent stock price performance?
Cloud DX Inc. (CDXFF) moves on earnings results, analyst revisions, sector rotation, and market sentiment. Notable catalyst: Comprehensive remote patient monitoring platform. See the News tab for the latest drivers. Past performance does not predict future results.
Should investors consider CDXFF overvalued or undervalued right now?
Valuing Cloud DX Inc. (CDXFF) requires multiple metrics. Compare P/E, P/S, and EV/EBITDA against sector peers for a full view.
What research should beginners do before buying CDXFF?
Before investing in Cloud DX Inc. (CDXFF), research these four areas: (1) the company's revenue model and competitive position (see Company Overview), (2) financial health through revenue growth, margins, and cash flow (see MoonshotScore), (3) what Wall Street analysts recommend and their price targets (see Analyst tab), and (4) specific risk factors that could impact the stock (see Risk Factors section).
Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.
Official Resources
Data provided for informational purposes only.
- Financial data is based on the most recent available information.
- OTC market data may be limited and less reliable than data for exchange-listed stocks.
- AI analysis is pending and may provide additional insights in the future.